Can a pregnant woman have herpes simplex virus type 2 (HSV-2) without it showing up in a lab test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Herpes Simplex Virus Type 2 (HSV-2) in Pregnancy: Detection and Management

Yes, it is possible for a pregnant woman to have herpes simplex virus type 2 (HSV-2) infection without it showing up in a lab test. This occurs due to limitations in testing sensitivity and the nature of viral shedding patterns 1.

Why HSV-2 May Not Be Detected During Pregnancy

  • Intermittent viral shedding: HSV-2 can remain dormant in nerve ganglia and shed intermittently, meaning the virus may not be actively replicating at the time of testing 1
  • Test limitations: No test is 100% sensitive, and false negatives can occur
  • Timing of infection: Recently acquired infections may not have produced sufficient antibodies for detection
  • Asymptomatic infections: Up to 80% of HSV-2 infections are asymptomatic, making clinical diagnosis challenging 1

Testing Considerations During Pregnancy

  • Type-specific serologic tests are recommended for diagnosing HSV-2 in pregnancy when clinical symptoms are present 1
  • Routine screening for HSV serostatus during pregnancy is not recommended by the American College of Obstetrics and Gynecology due to lack of evidence for cost-effectiveness 1, 2
  • Viral cultures during pregnancy do not reliably predict viral shedding at delivery and are not indicated routinely 1

Risks of HSV-2 in Pregnancy

  • Neonatal transmission risk is highest (30-50%) when a mother acquires genital herpes near the time of delivery 1
  • Risk is lower (approximately 3%) among women with recurrent herpes at term or who acquire HSV during the first half of pregnancy 1
  • Maternal genital herpes is a risk factor for perinatal mother-to-child HIV transmission in HIV-positive women 1

Management Recommendations

For Women with Known HSV-2 Infection:

  1. Suppressive therapy with acyclovir (400 mg TID) or valacyclovir (500 mg BID) starting at 36 weeks' gestation reduces:

    • Viral shedding
    • Recurrences
    • Need for cesarean deliveries 1
  2. Cesarean delivery is recommended for women with:

    • Genital herpes prodrome
    • Visible HSV genital lesions at the onset of labor 1
  3. Acyclovir is the antiviral drug with the most reported experience in pregnancy and appears to be safe; therefore, it is the first choice for therapy of HSV infections in pregnancy 1

For Women with Suspected New HSV-2 Infection:

  • Immediate testing with type-specific serologic tests and viral culture if lesions are present
  • Counseling about the high risk of transmission if infection occurs in late pregnancy
  • Avoidance of unprotected genital and oral sexual contact during late pregnancy, especially for susceptible women 1

Important Considerations

  • Breastfeeding should not be discouraged in HSV-infected mothers unless they have cracked nipples and detectable HSV DNA 1
  • Invasive fetal monitoring can increase the risk of neonatal herpes and should only be used for defined obstetrical indications 3
  • Safety of antivirals: Acyclovir has been extensively studied in pregnancy with no increased risk of major birth defects compared to the general population 1, 4

Prevention of Neonatal Herpes

  • Examine all women at the onset of labor for symptoms of genital herpes
  • Cesarean delivery significantly reduces HSV transmission rates among women with active HSV infection (1.2% vs 7.7% with vaginal delivery) 5
  • Avoid triggers that may cause recurrence near term (stress, UV radiation, local trauma) 4

Remember that the highest risk of neonatal infection occurs when the mother acquires genital HSV in the third trimester, making prevention of new infections during pregnancy a critical goal 3.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.